USH2A and hearing loss disorder: It has been shown that USH2A homozygous patients expressing a truncating mutation, such as the c.2299delG, develop significantly more severe hearing impairments throughout life compared to those expressing compound heterozygous mutations where one allele has a truncating mutation while the other allele has a non-truncating mutation, or patients with two non-truncating mutations51.